• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Herbal Medicine Classification: Policy Recommendations.

作者信息

Alostad Azhar H, Steinke Douglas T, Schafheutle Ellen I

机构信息

Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.

出版信息

Front Med (Lausanne). 2020 Feb 11;7:31. doi: 10.3389/fmed.2020.00031. eCollection 2020.

DOI:10.3389/fmed.2020.00031
PMID:32118016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7026670/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7476/7026670/53b128e612a8/fmed-07-00031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7476/7026670/53b128e612a8/fmed-07-00031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7476/7026670/53b128e612a8/fmed-07-00031-g0001.jpg

相似文献

1
Herbal Medicine Classification: Policy Recommendations.草药分类：政策建议。
Front Med (Lausanne). 2020 Feb 11;7:31. doi: 10.3389/fmed.2020.00031. eCollection 2020.
2
Traditional medicine policy and regulation in Nigeria: an index of herbal medicine safety.尼日利亚的传统医学政策与监管：草药安全性指标
Curr Drug Saf. 2014 Mar;9(1):16-22. doi: 10.2174/1574886308666131126155434.
3
Integrating biomedical and herbal medicine in Ghana - experiences from the Kumasi South Hospital: a qualitative study.加纳生物医学与草药医学的整合——库马西南部医院的经验：一项定性研究
BMC Complement Altern Med. 2016 Jul 7;16:189. doi: 10.1186/s12906-016-1163-4.
4
Implementing the medicines reconciliation tool in practice: challenges and opportunities for pharmacists in Kuwait.在实践中实施药物重整工具：科威特药剂师面临的挑战和机遇。
Health Policy. 2018 Apr;122(4):404-411. doi: 10.1016/j.healthpol.2017.12.011. Epub 2018 Jan 5.
5
An implementation model for health system reform.
Soc Sci Med. 1987;24(10):821-32. doi: 10.1016/0277-9536(87)90183-3.
6
Politics and ideology in migration policy formulation: the case of Kuwait.移民政策制定中的政治与意识形态：以科威特为例。
Int Migr Rev. 1989 Spring;23(1):24-47.
7
Diagnosis of public programs focused on herbal medicines in Brazil.巴西针对草药的公共项目诊断。
Nat Prod Commun. 2011 Jul;6(7):1001-2.
8
Use of traditional medicine for primary headache disorders in Kuwait.科威特原发性头痛疾病的传统医学应用。
J Headache Pain. 2018 Dec 4;19(1):118. doi: 10.1186/s10194-018-0950-3.
9
Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study.中国领先的医药改革真的解决了医疗服务费用过高的问题吗？一项实证研究的证据。
PLoS One. 2018 Jan 16;13(1):e0190320. doi: 10.1371/journal.pone.0190320. eCollection 2018.
10
Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China.县级公立医院药物利用趋势分析：以中国医疗卫生体制改革试点地区为例的研究
BMC Health Serv Res. 2018 Oct 23;18(1):812. doi: 10.1186/s12913-018-3614-8.

引用本文的文献

1
1H NMR spectra as a characteristic of herbal preparations.作为草药制剂特征的核磁共振氢谱。
J Food Sci Technol. 2025 Jul;62(7):1338-1349. doi: 10.1007/s13197-024-06107-9. Epub 2024 Oct 17.
2
Complementary authentication of Chinese herbal products to treat endometriosis using DNA metabarcoding and HPTLC shows a high level of variability.使用DNA宏条形码和高效薄层层析法对治疗子宫内膜异位症的中草药产品进行补充鉴定，结果显示出高度的变异性。
Front Pharmacol. 2023 Dec 5;14:1305410. doi: 10.3389/fphar.2023.1305410. eCollection 2023.
3
Horizon scan of DNA-based methods for quality control and monitoring of herbal preparations.

本文引用的文献

1
A qualitative exploration of Bahrain and Kuwait herbal medicine registration systems: policy implementation and readiness to change.对巴林和科威特草药注册系统的定性探索：政策实施与变革准备情况
J Pharm Policy Pract. 2019 Oct 9;12:32. doi: 10.1186/s40545-019-0189-7. eCollection 2019.
2
What has been the impact of the Traditional Herbal Registration (THR) scheme in the UK on information provided with herbal products bought over the counter?英国传统草药注册（THR）计划对非处方购买的草药产品提供的信息有何影响？
BMC Complement Altern Med. 2019 Apr 11;19(1):85. doi: 10.1186/s12906-019-2494-8.
3
International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain.
基于DNA的草药制剂质量控制与监测方法的前沿扫描
Front Pharmacol. 2023 May 3;14:1179099. doi: 10.3389/fphar.2023.1179099. eCollection 2023.
4
Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems.中国中成药产品进入中国医疗保障体系：对传统医学融入卫生系统国际一体化的启示。
Chin Med. 2022 Jan 4;17(1):5. doi: 10.1186/s13020-021-00560-w.
5
International policies and challenges on the legalization of traditional medicine/herbal medicines in the fight against COVID-19.国际政策与传统医学/草药在抗击 COVID-19 中合法化的挑战
Pharmacol Res. 2021 Apr;166:105472. doi: 10.1016/j.phrs.2021.105472. Epub 2021 Feb 14.
五种草药注册制度的国际比较以指导监管发展：英国、德国、美利坚合众国、阿拉伯联合酋长国和巴林王国。
Pharmaceut Med. 2018;32(1):39-49. doi: 10.1007/s40290-018-0223-0. Epub 2018 Jan 20.
4
Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series.与草药和膳食补充剂相关的肝毒性：病例报告在线表格。5 系列文章的第 2 部分。
Food Chem Toxicol. 2017 Sep;107(Pt A):472-501. doi: 10.1016/j.fct.2016.07.001. Epub 2016 Jul 8.
5
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.美国草药和膳食补充剂相关肝毒性的科学与监管视角
Int J Mol Sci. 2016 Mar 3;17(3):331. doi: 10.3390/ijms17030331.
6
Challenges and guidelines for clinical trial of herbal drugs.草药临床试验的挑战与指南
J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):329-33. doi: 10.4103/0975-7406.168035.
7
Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review.草药、膳食和减肥补充剂导致的肝损伤：综述。
J Clin Transl Hepatol. 2015 Jun 28;3(2):93-8. doi: 10.14218/JCTH.2015.00006. Epub 2015 Jun 15.
8
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.草药使用的日益增加：与不良反应相关的问题及安全性监测面临的挑战。
Front Pharmacol. 2014 Jan 10;4:177. doi: 10.3389/fphar.2013.00177.
9
A systematic review of barriers to and facilitators of the use of evidence by policymakers.政策制定者使用证据的障碍与促进因素的系统评价
BMC Health Serv Res. 2014 Jan 3;14:2. doi: 10.1186/1472-6963-14-2.
10
Future development of global regulations of Chinese herbal products.中草药全球监管法规的未来发展。
J Ethnopharmacol. 2012 Apr 10;140(3):568-86. doi: 10.1016/j.jep.2012.02.029. Epub 2012 Feb 25.